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The effects of mycotoxins in the production of animal feed were investigated using broiler chickens. For the feeding trial, naturally
Fusarium mycotoxin-contaminated wheat was used, which mainly contained deoxynivalenol (DON). The main effects of DON are
reduction of the feed intake and reduced weight gain of broilers. At the molecular level, DON binds to the 60 S ribosomal subunit
and subsequently inhibits protein synthesis at the translational level. However, little is known about other effects of DON, for
example, at the transcriptional level. Therefore, a microarray analysis was performed, which allows the investigation of thousands
of transcripts in one experiment. In the experiment, 20 broilers were separated into four groups of five broilers each at day 1 after
hatching. The diets consisted of a control diet and three diets with calculated, moderate concentrations of 1.0, 2.5 and 5.0 mg
DON/kg feed, which was attained by exchanging uncontaminated wheat with naturally mycotoxin-contaminated wheat up to the
intended DON concentration. The broilers were held at standard conditions for 23 days. Three microarrays were used per group to
determine the significant alterations of the gene expression in the liver (P, 0.05), and qPCR was performed on the liver and the
jejunum to verify the results. No significant difference in BW, feed intake or feed conversion rate was observed. The nutrient uptake
into the hepatic and jejunal cells seemed to be influenced by genes: SLC2A5 (fc: 21.54, DON2.5), which facilitates glucose and
fructose transport and SLC7A10 (fc: 11.49, DON5), a transporter of D-serine and other neutral amino acids. In the jejunum, the
palmitate transport might be altered by SLC27A4 (fc: 21.87, DON5) and monocarboxylates uptake by SLC16A1 (fc: 21.47, DON5).
The alterations of the SLC gene expression may explain the reduced weight gain of broilers chronically exposed to DON-contaminated
wheat. The decreased expressions of EIF2AK3 (fc: 21.29, DON2.5/5) and DNAJC3 (fc: 21.44, DON2.5) seem to be related to
the translation inhibition. The binding of DON to the 60 S ribosomal subunit and the subsequent translation inhibition might be
counterbalanced by the downregulation of EIF2AK3 and DNAJC3. The genes PARP1, MPG, EME1, XPAC, RIF1 and CHAF1B are
mainly related to single-strand DNA modifications and showed an increased expression in the group with 5 mg DON/kg feed.
The results indicate that significantly altered gene expression was already occurring at 2.5 mg DON/kg feed.
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Implications
The mycotoxin deoxynivalenol (DON) is a frequently detected
compound produced by moulds, which grow on wheat and
other cereals during pre-harvest. The main effects of DON in
broilers are reduced feed consumption and weight gain. The
measurement of the gene expression in the liver gave indica-
tions on the functional mechanism of DON. Genes related to
altered nutrient uptake to the cell, detoxification, altered
protein synthesis rate and DNA repair mechanisms could be
detected. With the description of new pathways, a better
understanding of the effects of DON on the metabolism of
broiler chicks can be expected.
Introduction
About 25% of the world’s food crops are contaminated with
mycotoxins. The most frequently occurring and widespread
mycotoxin in feedstuffs for poultry in European countries is
deoxynivalenol (DON) (Awad et al., 2004). The mycotoxin-
contaminated wheat used in this study contained mainly
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DON, in addition to a very low contamination with T-2 toxin and
zearalenone (ZON) in relation to maximal guidance values in
the European Union (EU). DON is a type B trichothecene, a
secondary metabolite produced by Fusarium species mainly
from Fusarium graminearum and Fusarium culmorum. Owing to
the growth of the fungi on maize, wheat and other cereals,
poultry feed can contain DON (Rotter et al., 1996; Awad et al.,
2004). In the EU, the maximal permitted value for feed con-
tamination is 5 mg DON/kg feed in poultry nutrition. At that
level, no damage to the birds is expected (European Union,
2006). However, decreased feed intake, weight gain and
reduced peripheral blood monocytes have been observed in
broilers fed 9.3 mg/kg DON in the grower phase (Swamy
et al., 2004). DON fed to pigs either in a purified form or in
the form of naturally contaminated corn led to reduced
weight gain and feed intake. Until the end of the experiment,
the animals receiving the purified DON recovered from the
growth depression in contrast to the animals receiving naturally
contaminated corn. The differences between naturally DON-
contaminated feed sources and the feed spiked with purified
DON might be caused by fungal components present in the
naturally mycotoxin-contaminated feed (Prelusky et al., 1994).
We decided to use naturally mycotoxin-contaminated wheat
for the experiment to reproduce the effects that occur in the
commercial broiler production. It was suggested that the DON
tolerance of broilers results from poorer toxin bioavailability and
rapid elimination from the body. DON is rapidly absorbed in the
upper part of the gastrointestinal tract and is also quickly cleared
from the body of the chickens. It has been suggested that an
efficient clearance takes place due to a hepatic or renal first-
pass effect in chickens. The oral administration of 14C-DON to
chickens showed high radioactivity in the liver and bile, with
more than 90% of the original label occurring in the excreta
before 48 h (Awad et al., 2008). Another experiment showed
that in hens administered 3H-DON, an overwhelming amount of
radioactivity was detected in the urine, demonstrating the
absorption of DON by the digestive system (Lun et al., 1989).
The main DON metabolite detected in urine and faeces was
de-epoxy DON (DOM-1) (Yoshizawa et al., 1986). Therefore, the
liver, as a direct target of DON, was chosen to analyse the gene
expression with microarrays. It has been suggested that cells
and tissues with high protein turnover rate, such as the liver and
small intestine, are most affected by DON (Awad et al., 2008). It
was also observed that fast-growing broilers are more suscep-
tible to DON than laying hens (Rotter et al., 1996). Pestka (2007)
claimed that DON is metabolised in all species, and that it
does not accumulate. The main effect of DON is the binding to
the 60 S ribosomal subunit and the subsequent prevention of
polypeptide chain initiation or elongation (Ueno, 1984). Further,
DON affects the immune system either as an immunosuppres-
sive or immunostimulative, depending on the dose and expo-
sure regime. The immunosuppression was explained mainly by
the binding capacity of DON to the ribosomes and by the
inhibition of protein synthesis (Bondy and Pestka, 2000).
However, there is little or no information available about the
involvement of DON in the pathways of immune suppres-
sion, nutritional uptake or detoxification within the living
animal. Most of the studies at the cellular level focused
on the acute effects of DON administration. Long-term
effects of DON-contaminated cereals seem to be important
for animal production because of a regular occurrence of
DON-contaminated feed.
The microarrays used in our experiment contained 37 000
probe sets corresponding to more than 28 000 genes. Espe-
cially when little is known about the molecular effects of a
substance, the use of microarrays as a screening method pro-
vides an invaluable starting point. The sequence of the probe
sets was designed according to the sequence information from
all transcribed genes, including the ones with an unknown
function. The profiling of gene expression with microarrays
should help gain insight into the effects and metabolism-related
genes upon DON administration. In addition, the expression of
genes, with a biological relevance to DON administration, was
verified with reverse transcription (RT) qPCR in the liver and the
jejunum, to cover the main target organs of DON. Possible
marker genes and affected pathways should be identified to
achieve a better understanding of how chronic and low doses
of mycotoxin-contaminated feed uptake affects liver and the
small intestine cells in broilers. In addition, the concentration at
which DON influences the gene expression in the liver should
be reviewed.
Material and methods
Experimental design, birds and diets
Twenty 1-day-old male ROSS 308 broiler chicks were obtained
from the commercial hatchery Erb Bru¨terei AG (Oberdiessbach,
Switzerland). The birds were weighed at the beginning of the
experiment and separated into four treatment groups according
to similar group weight. Five broilers per treatment group per
cage were raised together for 23 days. A standard diet (Table 1)
was formulated according to the National Research Council
(1994) and prepared for all groups in the same process. DON
(52 mg/kg) was added to the basic feed mixture of the treat-
ment groups in the form of mycotoxin-contaminated wheat.
DON was determined in the diets using LC–MS/MS; the other
mycotoxins were determined in the contaminated wheat
because of their low concentration, which was close to or
below the detection level in the diet. T-2 toxin and ZON con-
centrations of the contaminated wheat were determined using
LC–MS/MS; ochratoxin A, fumonisin B1 and B2 and aflatoxin
B1, B2, G1 and G2 were determined with HPLC-fluorescence
derivatisation in an external laboratory (UFAG; Sursee,
Switzerland). The pelleted feed and water were provided
ad libitum from day 1 onwards. The animal experiment was
performed in accordance with the regulations of the canto-
nal veterinary office in Zurich.
The total cage weight and feed intake were monitored on
a weekly basis. Total water intake per cage was recorded for
4 days a week. Feed samples were taken from the principal
components, the control and the treatment diet before and
after pelleting and on days 1 and 23 of the experiment. All
the feed samples were stored in a 48C cooler. Excreta sam-
ples were taken from days 8 to 11 and from days 15 to 18
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from all four cages and stored at2208C. Dry matter, ash, gross
energy, crude fat and crude protein content were determined in
all feed and excreta samples (Table 1). Apparent metabolisable
energy intakes (AME) and nitrogen (N) retention were cal-
culated according to the method described by Scott and Hall
(1998). After 23 days, broilers were weighed individually
and slaughtered by cervical dislocation. Liver samples were
removed immediately and washed, and from the middle
portion of the left liver lobe, a slice of about 1 cm width was
cut and frozen in liquid N. In a similar way, a slice of the
jejunum was collected; first 7 cm below the angle of Treitz, a
4-cm-long piece from the jejunum was cut out, and then the
lumen was opened and rinsed with 0.9% NaCl before it was
also frozen in liquid N.
High-density oligonucleotide array hybridisation
Total RNA was isolated from 12 frozen liver samples with
TRIZOL reagent (Invitrogen, Basel, Switzerland). From all
four groups, three samples were selected according to the
weight of the birds. The heaviest and lightest birds were
excluded. The samples were homogenised in a mortar filled
with liquid N. After isolation, RNA concentration and purity
were determined with an ND-1000 (NanoDrop Technologies,
Wilmington, DE, USA) and further cleaned up with the
RNeasy Mini Kit (Qiagen, Hilden, Germany). Before RT, the
RNA integrity was determined using a Bioanalyzer 2100
(Agilent Technologies, Basel, Switzerland). The integrity
number was calculated using the Bioanalyzer 2100 software
with a value between 1 (for totally degraded RNA) and
10 (for undegraded RNA). For the microarray experiments,
only samples with a value higher than 9 were taken. Labelled
cRNA probes were generated according to the protocol from
Affymetrix using the GeneChip One-Cycle cDNA Synthesis
Kit (Affymetrix, Santa Clara, CA, USA). The procedure con-
sisted of RT of 7mg total RNA with a T7 oligo (dT) promoter
primer and a second-strand cDNA synthesis, followed by an
in vitro transcription to biotin-labelled cRNA. Finally, the
labelled cRNA was fragmented and hybridised at 458C for 16 h
on the Chicken Genome Arrays (Affymetrix, Santa Clara, CA,
USA). For every sample a single microarray was used. The
arrays were washed and stained using the GeneChip Fluidics
Station and scanned with a GeneChip Scanner 3000 according
to the manufacturer’s protocol (Affymetrix, Santa Clara, CA,
USA). The GeneChip operating software (GCOS, Affymetrix,
Santa Clara, CA, USA) controlled the scanner and the fluidics
station. The data were analysed with the Microarray Suite
version 5.0 (MAS 5.0) using Affymetrix default analysis settings
and global scaling as a normalisation method. The image data
on each individual chip were scaled to target intensity 500.
RT and qPCR
To verify the results from the microarray experiment, the
total RNA was extracted from the remaining liver and the
jejunum samples. RNA extraction, quantification and quality
control were performed in the same manner as the microarray
samples. The experiments for 20 samples per tissue were
conducted in two steps: first, the RT was performed using the
High-Capacity cDNA Reverse Transcription Kit (Applied Bio-
systems, Rotkreuz, Switzerland) and then the real-time PCR
(qPCR) was conducted with adjusted amounts of cDNA. The
genes for the qPCR were selected after the gene expression
analysis and the literature review, depending on their possible
biological relevance in relation to mycotoxin-contaminated
feed. Primers were designed with Primer Express 3.0 soft-
ware (Applied Biosystems, Rotkreuz, Switzerland) on two
adjoining exons in order to exclude a possible amplification
due to genomic DNA contamination. The two endogenous
controls mitochondrial ribosomal protein S18A (MRPS18A)
and ribosomal protein S17 (RPS17 ) turned out to perform the
best for adjusting the cDNA concentration, compared with the
traditional and other selected control genes such as GAPDH,
b-actin, DHRS7, RPS28, APOB and LDHA. Genes and the
corresponding primer pairs are indicated in Table 2. The 20-ml
qPCR reaction contained 500 nM of forward and reverse
primers, 100 ng of sample cDNA and 10ml Fast SYBR Master
Mix (2X; Applied Biosystems, Rotkreuz, Switzerland). The PCR
amplification was performed on the 7500 Fast real-time
PCR System with SDS Software 1.3.1 (Applied Biosystems,
Table 1 Broiler diets
Control DON1 DON2.5 DON5
DON (mg/kg) 0 1 2.5 5
Ingredients (%)
Corn 17.5
Soybean meal 48% 25.0
Potato protein 2.5
Rapeseed oil 5.0
Salt 0.15
DL-methionine 0.26
Limestone grit 0.90
Lysine-HCL 0.17
DCP 38/40 1.20
Na-bicarbonate 0.30
Celite 545 1.52
Premix1 0.50
Contaminated wheat 0 1.92 4.80 9.62
Uncontaminated wheat 45.00 43.08 40.19 35.39
Analyzed parameters
DON (mg/kg) 0.32 0.88 2.21 4.42
T-2 toxin (mg/kg) 0 1.0 2.5 5.1
ZON (mg/kg) 0 6.7 16.8 33.7
Dry matter (%) 90.9 90.9 91.2 91.2
G.E. (MJ/kg) 15.85 15.85 15.94 15.74
Crude fat (%) 6.81 6.97 7.03 6.97
Crude protein (%) 20.76 20.73 20.86 20.88
Ash (%) 6.47 6.57 6.70 6.66
DON5 deoxynivalenol; DCP5 di-basic calcium phosphate; ZON5 zearalenone;
G.E.5 gross energy.
Contaminated wheat (52 mg DON/kg), uncontaminated wheat (0.58 mg DON/kg).
Maximal allowed contamination per kg feed of poultry in European Union (2006;
percentage in group DON5 of maximal allowed concentration): DON: 5 mg/kg
(88.5%), T-2: 150mg/kg (3.4%), ZON: no recommendations. Mycotoxins below
the detection limits: aflatoxin B1, B2, G1, G2 (1.3mg/kg feed), ochratoxin A
(1mg/kg feed) and fumonisin B1, B2 (10mg/kg feed).
1Premix: diet from Aeschbacher et al. (2005).
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Rotkreuz, Switzerland) and repeated four times separately.
The cycling programme was 20 s at 958C and then 40 cycles of
the following: denaturation for 3 s at 958C, annealing and
extension at 608C for 30 s. The results were evaluated with the
comparative Ct method (2244Ct) with the SDS software.
Statistical analysis
The alterations in the expression profiles between the control
and the treatment groups were analysed using the GeneSpring
7.3 software (Agilent Technologies, Basel, Switzerland). Nor-
malisation was carried out with GeneSpring 7.3 and the default
settings as follows: values below 0.01 were set to 0.01; each
measurement was divided by the 50th percentile of all mea-
surements in that sample and each gene was divided by the
50th percentile of its measurements in all the samples. The pre-
filtering was performed according to Pepper et al. (2007) as
follows: the genes had to be present or marginal in all samples,
and the raw value had to be above the 50th percentile, of all
present and marginal genes, in all samples of a group to
remove genes with a low signal strength. The gene lists from
the four groups were merged together, and Student’s t-test was
performed between the control and each treatment group
(P,0.05). Further, genes were grouped into seven subgroups:
first, genes with significant changed expression in only one
group (DON1, DON2.5, DON5) compared with the control
group; then, genes within two groups (DON1/2.5, DON2.5/5,
DON1/5) compared with the control group and genes within all
three groups (DON1/2.5/5) compared with the control. Finally,
for every subgroup a t-test was performed and the P-values are
indicated in Tables 4 and 5. The fold changes were listed for
every comparison. The final gene list was separated into groups
of up- and downregulated genes. The microarray raw data have
been deposited into the Gene Expression Omnibus (National
Center for Biotechnology Information, http://www.ncbi.nlm.
nih.gov/geo) with accession number GSE25185. Genes with an
average raw value above the 80th percentile, of all present and
marginal genes, in the group with the significantly changed
expression are indicated with an asterisk (Tables 4 and 5).
The average raw value was indicated to estimate the
importance of a gene in cellular processes. All the other
measured parameters were analysed using Student’s t-test
to determine significance (P, 0.05).
Results
Diet characterisation and performance of broilers
The DON concentration of the control diet was 0.32 mg/kg
feed, which was close to the detection level of 0.2 mg DON/
kg. The DON concentration in DON1 was 0.89 mg/kg,
2.21 mg/kg for DON2.5 and 4.43 mg/kg for DON5. The cal-
culated T-2 toxin and ZON concentrations in group DON5
were low, with values of 5.1 and 34.6mg/kg feed, respec-
tively. The other measured mycotoxin concentrations were
below the detection limit. The performance of the broilers
within the groups was balanced, and they did not show an
abnormal behaviour or other indications due to DON con-
tamination. The progression of growth and the feed intake
were within the range of expectation (Table 3). No behav-
ioural or macroscopic pathological alterations were detected
in the appearance of liver, stomach, intestine, spleen, heart,
muscles and lungs of the broilers receiving the mycotoxin-
contaminated feed.
The parameters for the RNA quality and quantity, as well
as the microarray quality parameters, were within the
requirements. In Tables 4 and 5, a summary of genes with an
altered expression are sorted according to the DON groups.
Table 2 Primer sequence for qPCR
Gene Forward Reverse
MRPS18A GGGAAGCGGCTGGGTTT ATTATGGTCGTGTTGCCTTCAGT
RPS17 TGGATGCGCTTCATCAAGTG TCATCCCCCAGCAAGAAAGT
AKR1B1 TTAAAGAGATTGCAGCCAAGCA TCACGTTTCTCTGGATGTGGAA
CASP1 GCAGGAGATGTTCCGAAAGG ACTTCTTCAGCATTGTAGTCCTCTCTT
EIF2AK3 CCTGTTCTGCCTCATCGTCAT ACTCAGGGAAGGTGAAGTACATCTG
EP300 GGCTGAGCTGTTGGCATAGC TCAACCATGAATTCCCAAAACTC
EXOSC9 CGCGTTCCTCTCGTTCATTT CCTATTTGTGTCAGTTTTGCCTTCT
IFT57 AGGATTAGTGGGCAGTGCAAA GCTGAAGCTGCTGAGCTACGA
LAPTM4B CAGGACTACCTTCGCCAGCT TTCCTTGTAAGGAAAGTTGCTGG
MIA2 GGAATGTGAGACGGCAATGA TCCCCTGTTTTGAAGCTCAGA
MAPKAPK3 TGGTCTCTGGGTGTCATCACA AAATAGCTTGTCCAGTGTTCGAGTAG
TP53I3 TGGCCAAGCTGAATATGTTACAGTA GCTGCAGCCTGAATAAAAGTCA
SLC2A5 ACTGCAGCAACAATGGAGAAGA GGTGGGACCTCTGGTCAACA
SLC7A10 TGTAAATATATCCTGAATGCGTGTTG CTAGGATTCTCTCCATGGTGTGTTT
SLC16A1 GCAGGGTTCAGGTTAAATGCA CACCGTGGAGGAGCTCTACTTC
SLC27A4 TCCTGCCTTCCCCTCAATG CGCATCCTCAACCTGACAGA
STK39 ACTCGTAACAAAGTAAGGAAAACATTTG CCTCGCACCTGCTCCATTA
TJP1 TCTTGCTGTGGCTACAACAGTGT AATGCTGTGCCTAAAGCCATTC
XRN1 ACTTCACTGAAGTGCTCACGATCA GATATTTCTCAAAGCGCTTTAAATTCAG
50–30 direction.
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The expression of a total of 566 genes was significantly
altered in DON groups compared with the control group
(supplementary files). The heatmap of the cluster analysis of
all significantly altered genes between the control and the
DON-containing groups is shown in Figure 1.
The entire list of up- and downregulated genes is available
in the section of supplementary files. In the DON groups, 367
genes were upregulated. Of these, 230 genes have been
specified in relation to their function or structure, and for 138
genes only the transcript sequence is known. The average
expression of 152 upregulated genes, or 41% of the upre-
gulated genes, was above the 80th percentile of the raw
value of all genes, which is indicated by an asterisk (*) in the
column ‘Fold change’ (Tables 4 and 5). The fold change of
28 genes was above two. Venn diagrams are presented in
the section of supplementary files with the distribution of
significantly altered genes between the treatment groups.
A summary of discussed genes with an upregulated expre-
ssion in the DON groups is presented in Table 4.
In Table 5, the most important and significantly down-
regulated genes are indicated according to the DON groups.
Of 199 significantly downregulated genes, the function of 139
genes was known. Sixty genes were unknown or no function
could be assigned to them; 14 genes had a fold change higher
than two; and 45 genes, or 32% of the downregulated genes,
had a raw value above the 80th percentile.
RT and qPCR
The results from the microarray experiment were verified
with RT qPCR, and the results are shown in Table 6. The
alterations could be confirmed for 9 of the 15 genes in the
liver. A total of 10 of 17 genes showed a significantly altered
expression in the liver and the jejunum. The correlation
between the fold changes of the qPCR experiment and the
microarray analysis in group DON5 was 0.75. XRN1 and
SLC16A1 expression were measured because of their bio-
logical relevance. The genes AKR1B1, MIA2, SLC2A5,
SLC7A10 and LAPTM4B were significantly regulated in the
liver, measured with qPCR and microarrays, as well as in the
jejunum tissues. SLC27A4, CASP1 and EP300 had a sig-
nificant altered expression in the microarray experiment in
the liver and in the qPCR experiment in the jejunum. The
alteration of the expression for the genes EXOSC9, TJP1,
EIF2AK3 and IFT57 could be confirmed only in the liver by
qPCR. SLC16A1 was not significantly altered in any mea-
surement in the liver, but showed a decreased expression in
the jejunum groups. The reduced expression of XRN1 did not
reach significance in the microarray analysis (P, 0.08), but
was significantly reduced in the qPCR measurement. The
expression alteration of the genes MAPKAPK3, STK39 and
TP53I3 could not be confirmed with qPCR in any tissues.
Taking the liver and jejunum groups together, 14 of 17
expression alterations could be confirmed with qPCR.
Discussion
The use of naturally mycotoxin-contaminated wheat resulted
primarily in a high DON contamination (4.425 mg/kg) and a
low calculated contamination with T-2 (5.1mg/kg) and ZON
(33.7mg/kg) in the final feed mixture of DON5. Because of
the low calculated concentrations of T-2 and ZON approxi-
mately or below the detection level, they were measured in
naturally mycotoxin-contaminated wheat. The other mea-
sured mycotoxins in the mycotoxin-contaminated wheat
were below the detection limit. The maximal allowed con-
centration for DON in poultry feed is 5 mg/kg feed and
150mg/kg feed for T-2. No maximal guidance values exist
for ZON (bovine: 500mg/kg feed), because of the high
tolerance of poultry. The maximal permitted mycotoxin
concentrations are related to the level at which no damage
to the birds is expected (EFSA, 2004). The mycotoxin analysis
in the final feed mixture showed, in comparison with the
maximal permitted concentration, a proportion of 88.5% of
DON, 3.4% of T-2 and 6.7% of ZON (bovine guidance value)
in the feed of group DON5. Because of the high proportion of
DON and the low amount of T-2 and ZON, we considered the
observed alterations at the transcriptional level due to the
effects of DON. Most of the reported effects have been
investigated mainly in cell cultures or model organisms such
as mice. In our experiment, we showed for the first time
similar alterations in the gene expression in broilers.
The growth, feed intake and feed conversion rates were
within the normal range in our experiment. Although BW
and feed intake were numerically the lowest in group DON5
and the highest in group DON2.5, this was statistically not
significant. It has been mentioned by Awad et al. (2008) that
Table 3 Performance parameters
Control % DON 1 % DON 2.5 % DON 5 %
BW day 22 (g)6 s.e. 11186 36.0 11406 19.8 12016 30.1 10846 80.4
FI week 3 (g) 807 839 908 771
FCR (g/g) 1.50 1.53 1.60 1.54
AME P1 (MJ/kg)/(%) 15.27 100 14.97 98.1 15.44 101.2 14.75 96.6
AME P2 (MJ/kg)/(%) 14.74 100 14.73 99.9 14.89 101.1 13.87 94.1
N retention P1 (%) 67.74 100 64.72 95.5 69.26 102.3 66.47 98.1
N retention P2 (%) 65.08 100 63.64 97.8 63.79 98.0 59.20 91.0
DON5 deoxynivalenol; FI5 feed intake; FCR5 feed conversion rate (g gain/g feed); AME P1/25 apparent metabolisable energy in MJ/kg
dry matter and % relative to the control; P1/25 period 1 or 2.
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Table 4 Upregulated genes in DON group
Systematic name Name Fc P Description Function
Upregulated in DON 1, DON 2.5 and DON 5
Affx.10275.1.S1_at SAMD12 1.9, 1.9, 2.0 0.033 Sterile alpha motif domain containing 12 Signalling
9157.1.S1_at COX19 1.4, 1.7, 1.6 0.016 Cytochrome c oxidase assembly homologue Metal transport
Affx.11292.2.S1_s_at LOC425649 1.9, 1.5, 1.4 0.006 Similar to rhomboid family 1 Epidermal growth factor receptor
3382.1.S1_at PPIB 1.4, 1.2, 1.4 0.015 Peptidylprolyl isomerase B (cyclophilin B) Immune system
Affx.1528.1.S1_at MAPKAPK3 1.5, 1.3, 1.3 0.001 Mitogen-activated protein kinase APK3 p38 MAPK pathway
Upregulated DON 2.5 and DON 5
Affx.24663.2.S1_s_at IFT57 2.0, 3.0 0.004 Intraflagellar transport 57 homologue Regulation of Apoptosis
Affx.4365.1.S1_at LOC416968 1.9, 2.0 0.012 Similar to presenilin-like protein 4 Peptidase
2529.2.S1_a_at IL1RL1 1.7, 1.7 0.024 Interleukin 1 receptor-like 1 Innate immune response
9700.2.S1_a_at TSPAN7 1.4, 1.4 0.017 Tetraspanin 7 Signal transduction
Upregulated in DON 1 and DON 2.5
Affx.12452.1.S1_s_at KLF11 2.5, 2.1* 0.015 Kruppel-like factor 11 Neg. regulation of cell proliferation
Upregulated in DON 1 and DON 5
16554.2.S1_a_at LAPTM4B 4.2, 3.1 0.013 Lysosomal associated prot. Transmem. 4b
10204.1.S1_s_at CASP1 1.8, 2.2 0.006 Caspase 1 Apoptosis/interleukin 1 convert.
11819.1.S1_at CENPQ 1.6, 1.8 0.032 Centromere protein Q Centromeric complex
Affx.10735.1.S1_at MITD1 1.6, 1.7 0.005 Microtubule interact./transp. dom. cont. 1 Protein transport
2952.1.S1_at CLDN3 1.6, 1.6 0.031 Claudin 3 Leukocyte transendothelial migrat.
Affx.12447.1.S1_at SLC16A9 2.0, 1.6 0.002 Solute carrier fam. 16, mem. 9 Monocarboxylic acid transporter
3364.2.S1_at LOC425437 1.7, 1.5 0.025 Similar to phosphatidylinositol glycan B Glycolipid mannosyltransf. activity
2252.1.S1_s_at RAB33B 1.5, 1.4 0.018 RAB33B, member RAS oncogene family Protein transport
Affx.11111.1.S1_s_at GDPD5 2.1, 1.4 0.017 Glycerophosphodiester phosphodiester. 5 Glycerol metabolic process
Upregulated in DON 5
12857.1.S1_s_at TP53I3 2.646 0.025 Tumor protein p53 inducible protein 3 Apoptosis by oxidative stress
Gga.13986.1.S1_at IFT57 2.617 0.003 Intraflagellar transport 57 homologue Regulaiton of apoptosis
4124.1.S1_at LOC395933 2.597* 0.028 Sulfotransferase Sulfotransferase activity
4332.1.S1_at HSPCB 1.972 0.030 Heat shock 90kDa protein 1, beta Response to unfolded protein
635.1.S1_at GLRX 1.901* 0.031 Glutaredoxin (thioltransferase) Cell redox homeostasis
Affx.7092.1.S1_at GNPAT 1.869* 0.029 Glyceronephosphate O-acyl-transferase Fatty acid metabolic process
Affx.12177.1.S1_s_at MCM5 1.832 0.022 Minichromosome maintenance complex 5 DNA replication, cell cycle
Affx.8046.1.S1_s_at SLC41A2 1.832 0.032 Solute carrier family 41, member 2 Cation transport
Affx.24672.1.S1_s_at PROS1 1.812* 0.011 Protein S (alpha) Blood coagulation
3251.1.S1_at NDUFS1 1.802 0.013 NADH dehydrogenase Fe-S protein 1 ATP metabolic process
Affx.12875.1.S1_at VPS29 1.779 0.037 Vacuolar protein sorting 29 homologue Protein transport
11184.1.S1_at KCTD12 1.757 0.016 Potassium channel tetram. dom. cont. 12 Potassium ion transport
7164.1.S1_at LOC421110 1.724 0.025 Similar to DNA replication initiator protein DNA replication initiation
5235.1.S1_at HYOU1 1.695* 0.005 Hypoxia upregulated 1 Response to hypoxia
Affx.5663.1.S1_at SMAD7 1.684 0.022 SMAD family member 7 Signalling
8338.1.S1_at NIP7 1.667* 0.047 Nuclear import 7 homologue Ribosome assembly
Affx.21723.1.S1_at GPSM1 1.645 0.001 G-protein signalling modulator 1 Cell differentiation
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Table 4 Continued
Systematic name Name Fc P Description Function
Affx.4506.2.S1_s_at RAB3IL1 1.634 0.014 RAB3A interacting protein (rabin3)-like 1 Guanylnucleotide exchange factor
7843.1.S1_at SYPL1 1.626* 0.016 synaptophysin-like 1 Transport
13290.1.S1_at RNFT1 1.582* 0.002 Ring finger protein, transmembrane 1 Metal ion binding
11918.1.S1_at NSUN3 1.582 0.009 NOL1/NOP2/Sun domain family 3 Transferase activity
Affx.12146.1.S1_at SNRPA1 1.558 0.033 Small nuclear ribonucleoprotein A RNA splicing
Affx.13032.1.S1_s_at KIF23 1.550 0.014 Kinesin family member 23 Mitotic spindle elongation
6206.1.S1_s_at CHMP6 1.536 0.028 Chromatin modifying protein 6 Protein transport
Affx.12982.1.S1_s_at COPB1 1.536* 0.027 Coatomer protein complex, subunit b 1 Vesicle-mediated transport
Affx.8553.1.S1_s_at PBX4 1.524 0.042 Pre-B-cell leukaemia homeobox 4 Transcription regulation
Affx.13133.1.S1_s_at BPGM 1.520 0.038 2,3-bisphosphoglycerate mutase Glycolysis
Affx.23087.1.S1_at NUBPL 1.515 0.037 Nucleotide binding protein-like Chromosome partitioning
8478.1.S1_s_at OTOA 1.513* 0.029 Otoancorin Transport
7249.1.S1_a_at CDT1 1.473 0.024 Chromatin licensing/DNA replication 1 Reg. of DNA replication initiation
Affx.20694.1.S1_s_at ORMDL1 1.468* 0.013 ORM1-like 1 Protein folding
2136.3.S1_at RHOU 1.437 0.017 Ras homologue gene family, member U Signal transduction
4314.1.S1_at P50 1.435 0.018 Dynamitin Microtubule-based process
8862.1.S1_s_at CHAF1B 1.435 0.033 Chromatin assembly factor 1, subunit B DNA replication
Affx.23168.1.S1_at ALDH6A1 1.429* 0.042 Aldehyde dehydrogenase 6 family A1 Propanoate metabolism
1737.1.S1_at SLC27A4 1.427* 0.027 Solute carrier family 27, member 4 Fatty acid transporter
6330.3.A1_at RNF7 1.425 0.030 Ring finger protein 7 Ubiquitin cycle Apoptosis
4774.1.S1_at LOC422278 1.422* 0.027 Nonhistone chrom. protein HMG-14A DNA binding
229.1.S1_at HINT1 1.414* 0.025 histidine triad nucleotide binding protein 1 Signal transduction
5209.1.S2_at ADPRT 1.410* 0.005 Poly (ADP-ribose) polymerase family 1 Base excision repair
840.2.S1_a_at P08296 1.406 0.003 Myosin alkali light chain mRNA Motor activity
Affx.22246.1.S1_at MPG 1.406 0.031 N-methylpurine-DNA glycosylase DNA repair
Affx.12559.1.S1_s_at SLC10A7 1.399 0.030 Solute carrier family 10, member 7 Sodium/bile acid cotransporter
Affx.21403.1.S1_s_at EME1 1.366 0.048 Essential meiotic endonuclease 1 DNA repair
2794.1.S1_at EP300 1.321* 0.029 E1A binding protein p300 Signal transduction
3310.1.S1_at XPAC 1.279* 0.046 Xeroderma pigmentosum, compl. A Nucleotide-excision repair
Affx.2936.1.S1_at SLC7A10 1.263 0.031 Solute carrier family 7, member 10 Neutral amino acid transporter
7684.1.S1_at MRPL46 1.256* 0.029 Mitochondrial ribosomal protein L46 Ribosomal protein
5561.1.S1_at RIF1 1.235 0.001 RAP1 interacting factor homologue Response DNA damage stimulus
Upregulated in DON 2.5
554.1.S1_at HGF 2.105 0.003 Hepatocyte growth factor Growth factor activity
7604.2.S1_a_at PLSCR1 1.812 0.012 Phospholipid scramblase 1 Phospholipid scrambling
5517.1.S1_s_at LOC421267 1.799 0.031 Similar to nuclear DNA-binding protein Apoptosis inducing
Affx.24639.1.S1_at FILIP1L 1.762 0.035 Filamin A interacting protein 1-like Cell proliferation
3674.1.S1_at STK39 1.650 0.001 Serine threonine kinase 39 Response to cellular stress
6223.1.S1_at ADAM33 1.621 0.014 ADAM metallopeptidase domain 33 Proteolysis
Affx.3622.2.S1_s_at ABCG2 1.600* 0.031 ATP-binding cassette, sub-family G 2 Response to drug biomarker
Affx.7445.2.S1_s_at CSTF3 1.560 0.029 Cleavage stimulation factor, 30 pre-RNA 3 mRNA processing
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moderately high concentration levels of DON can even have
growth-promoting effects. Further, the increased s.e. in BW
of group DON5 indicates that different sensitivity towards
DON-contaminated feed might exist, depending on the
genetic background of the animals.
Nutrient transport
The gene expression analysis has shown that the nutrient
uptake into the cell seems to be influenced by the mycotoxin-
contaminated feed. The passive D-fructose transporter with a
very low glucose affinity, SLC2A5 (fc:21.259, DON2.5), had
a decreased expression in the liver (fc: 21.54, DON2.5) and
the jejunum (fc: 21.94, DON2.5/5). The numerical decrease
in AME by 5.9% might be a further indication of a reduced
monosaccharide uptake in the jejunum. Maresca et al.
(2002) showed in their study that fructose uptake into the
cell and corresponding transporter SLC2A5 were inhibited by
42% in the intestinal cell line HT-29-D4 cells because of DON
administration. Our findings indicate that similar effects
occur in the jejunum of broilers in the living animal, and to a
lesser extent in the liver. The gene SLC27A4 (fc: 11.427,
DON5) is a palmitate transporter and the increased expres-
sion could not be confirmed with qPCR in the liver. However,
the expression was significantly reduced in the jejunum
(fc: 21.87, DON5). In primary enterocytes treated with
SLC27A4 antisense, palmitate and oleate uptake were
reduced simultaneously (Stahl et al., 1999). Maresca et al.
(2002) reported an increased palmitate uptake by 35% in
their study after challenging HT-29-D4 cells with DON. We
assume that chronic exposure to DON can invert the
regulation or that another functional mechanism on the
transport activity is responsible for the discrepancy between
the decreased expression of SLC27A4 in the jejunum and the
increased palmitate uptake reported by Maresca et al.
(2002). The SLC7A10 protein (fc: 11.26, DON5) transports
D-serine, glycine and L-isomers of alanine, serine, threonine
and cysteine (Nakauchi et al., 2000). The expression change
was confirmed with qPCR in the liver (fc:11.49, DON5) and
the jejunum (fc:12.52, DON5). Further, the N retention was
numerically reduced by 9%, which gives an indication on the
amino acid uptake. The decrease in L-serine uptake in the cell
culture study by Maresca et al. (2002) is in disagreement with
our observation that SLC7A10 showed an upregulated
expression, but is in agreement with the reduced N retention in
group DON5. The discrepancy could indicate a direct inhibition
of this L-serine transporter by DON, resulting in the upregula-
tion of SLC7A10. SLC7A5 (fc: 21.218, DON5) is a transporter
of neutral amino acids with branched or aromatic side chains
such as leucine (Kanai et al., 1998). In an incorporation study
with mice, the 14C leucine incorporation into the liver was
decreased at 20 mg DON/kg feed. It was assumed that DON
inhibited the protein synthesis, and therefore the reduction of
the 14C leucine amount occurred (Robbana-Barnat et al.,
1987). The addition of 0.5 and 5mg DON/ml to Caco-2 cells
led to a decreased [3H] leucine incorporation and a parallel
decrease of cellular protein content (De Walle et al., 2010). The
extent to which leucine uptake into the cell is responsible forTa
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the decrease of the protein synthesis remains unclear. In
a related, unpublished study, SLC16A1 expression was
significantly altered, and therefore the test was also used to
verify the expression in the jejunum in this study. SLC16A1
(fc:21.87, DON5) had a decreased expression in the jejunum,
and it transports monocarboxylates such as butyrate, lactate
and pyruvate (Lambert et al., 2002). It has been suggested that
effects of DON on membrane transport is a result of specific
modulation of the transporters and is not due to cell damage
(Maresca et al., 2002), which is supported by our observations,
especially because SLC7A10 was upregulated. The alteration
of these five gene expression levels influences the nutrient
uptake into the cell and might have implications for the growth
rate of birds.
Detoxification
AKR1B1 (fc: 23.511, DON2.5 and 5) had a decreased expres-
sion in the liver, measured with microarray and qPCR experi-
ments (fc: 22.5, DON2.5 and 5), as well as in the jejunum
(fc: 22.49, DON5). AKR1B1 reduces reactive aldehydes and
ketones to primary and secondary alcohols. Reactive oxygen
species also target polyunsaturated fatty acids that form lipid
Table 5 Downregulated genes in DON groups
Systematic name Name Fc P Description Function
Downregulated in DON 1, DON 2.5 and DON 5
19878.1.S1_at ARID1A 1.7, 1.7, 1.6 0.006 AT rich interactive domain 1A Andro./estrogen receptor signalling
14829.1.S1_at Mlh3 1.2, 1.3, 1.2 0.006 Sim. to DNA repair protein Mlh3 DNA repair
Downregulated in DON 2.5 and DON 5
Affx.26.1.S1_at LOC427047 1.6, 2.1 0.021 Sim. to breast cancer-associated antigen 1 Transcription regulation
Affx.12182.1.S1_at ODF2 2.0, 1.7 0.01 Outer dense fibre of sperm tails 2 Cell differentiation
Affx.5339.1.S1_at EXOC4 1.9, 1.7 0.005 Exocyst complex component 4 Protein transport
Affx.25933.3.S1_s_at PITPNC1 1.7, 1.6 0.006 Phosphatidylinositol transfer protein 1 Lipid transport
15747.2.S1_s_at APRIN 1.6, 1.5 0.017 Androgen-induced proliferation inhibitor Cell cycle
Downregulated in DON 1 and DON 2.5
6220.5.S1_a_at ICER 1.6, 2.0 0.006 ICER protein Transcription regulation
Affx.25502.2.S1_at SLC2A5 1.6, 1.3* 0.004 Solute carrier family 2, member 5 Glucose/fructose transport
Downregulated in DON 5
9580.2.S1_a_at AKR1B1 3.948* 0.047 Aldo-keto reductase family 1, member B1 Response to stress
12430.1.S1_at MIA2 2.544 0.013 Melanoma inhibitory activity 2 Inflammation
Affx.6850.1.S1_at BTBD7 1.769 0.001 BTB (POZ) domain containing 7 Related to tumourigenesis
14891.1.S1_s_at RBBP6 1.651 0.039 Retinoblastoma binding protein 6 Protein ubiquitination
9934.1.S1_s_at ANKRD13A 1.631 0.037 Ankyrin repeat domain 13A Probably DNA damage related
13135.2.S1_a_at ZCRB1 1.586 0.023 Zinc finger CCHC-type, RNA binding 1 RNA splicing
9603.1.S1_s_at USP8 1.529 0.021 Ubiquitin specific peptidase 8 Cell proliferation
12626.2.S1_s_at HCFC2 1.524 0.003 Host cell factor C2 Transcription regulation
Affx.26072.2.S1_s_at TJP1 1.52 0.025 Tight junction protein 1 (zona occludens 1) Intercellular junction assembly
3068.1.S1_at Trap150 1.511* 0.028 Sim. to thyroid hormone receptor-associ. Androgen receptor signalling
Affx.20095.1.S1_at EXOSC9 1.503 0.010 Exosome component 9 Immune response
Affx.26106.6.S1_s_at LOC428354 1.48 0.036 Sim. to Jumonji domain cont. protein 2B Transcription regulation
16149.1.S1_s_at ANKMY1 1.474 0.024 Ankyrin repeat and MYND domain 1 Protein binding
Affx.7493.1.S1_s_at LOC422658 1.473* 0.037 Sim. to UDP-glucuronosyltransferase 2A1 Detection of chemical stimulus
Affx.8082.2.A1_at ELOVL2 1.472* 0.030 Elongation of very long chain fatty acid L2 Fatty acid biosynthesis
Affx.21354.1.S1_at YPEL1 1.438* 0.039 Yippee-like 1 (Drosophila) Cell morphology
Affx.13221.1.S1_s_at MTPN 1.425 0.003 Myotrophin Cell growth
11668.1.S1_at NDRG1 1.395* 0.029 N-myc downstream regulated gene 1 Response to metal ion
Affx.12896.1.S1_at SLC7A5 1.218 0.003 Solute carrier family 7, A5 Cationic amino acid transporter
Downregulated in DON 2.5
12243.1.S1_at RWDD2B 1.891 0.023 RWD domain containing 2B Unknown
10529.1.S1_at LOC770294 1.702 0.008 Similar to RNase H, putative DNA integration
6038.1.S1_at LOC417856 1.649 0.045 Sim. to TMEM19 protein Multi-pass membrane protein
8763.1.S1_at YTHDC1 1.565 0.025 YTH domain containing 1 RNA splicing
Affx.21020.1.S1_s_at BAZ1B 1.541 0.035 Bromodomain adjacent to zinc finger 1B Chromatin remodelling
Affx.13074.1.S1_at DNAJC3 1.435 0.040 DnaJ (Hsp40) homologue, sub-family C3 Defense response
10975.1.S1_s_at ARID1B 1.407 0.040 Sim. to AT rich interactive dom. 1B, 1 Chromatin-med. transcription
Affx.10171.1.S1_at EIF2AK3 1.286 0.010 Eukary. Transl. initiation fact. 2-a kinase 3 Negative regulation of translation
DON5 deoxynivalenol; Fc5 fold change of groups DON1, DON2.5 and DON5; P5 P-value of Student’s t-test.
The systematic name of the probe sets in chicken is the species code Gga., followed by the identifier (e.g. GgaAffx.5975.1.S1_at or Gga.2439.1.S1_at).
*Raw value above the 80th percentile.
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hydroperoxides, which are finally decomposed to form reactive
lipid aldehydes, which are highly mutagenic. AKR1B1 detoxifies
those lipid aldehydes that can react with bases in DNA to form
etheno- and heptano-etheno-DNA adducts (Jin and Penning,
2007). The downregulation of AKR1B1 by chronic DON expo-
sure might also be in relation to several upregulated DNA repair
genes, which are discussed in the section below. In the human
hepatoma-derived cell line HepG2, the expression of AKR1B1
was significantly reduced after the cells were challenged with a
series of cytotoxic substances (Kawata et al., 2007). In conclu-
sion, AKR1B1 seems to be an interesting in vivo biomarker for
DON-induced alteration of gene expression.
DNA repair
Six genes were significantly upregulated in DON5 and one in
DON2.5, which are responsible for DNA damage repair and
recognition, showing a possible effect of DON on DNA
integrity. The six genes correspond to 4.1% of significantly
altered genes, with a known function, in group DON5. The
protein is involved in DNA repair and has a critical role in
signalling DNA single-strand breaks (Plummer and Calvert,
2007). Shifrin and Anderson (1999) showed that the addition
of DON to the Jurkat human lymphoid cell line led to the
activation of pro-caspase-3, leading to a higher cleavage of
PARP1, a substrate of caspase-3. In murine macrophages,
J774A.1, an increased amount of PARP1 and significantly
increased amount of cleaved PARP1 protein resulted after the
challenge with DON (Marzocco et al., 2009). The upregulation
of PARP1 therefore shows that similar effects might occur
in the liver of broilers. MPG (fc:11.406, DON5) is responsible
for the recognition and excision of alkylated purine bases
(O’Brien and Ellenberger, 2004). EME1 (fc: 11.366, DON5)
cleaves branched DNA structures. In the absence of EME1,
chromosomal aberrations occurred and led to genomic
instability (Abraham et al., 2003). The gene RAD51L1 (fc:
11.395, DON2.5) functions in homologous recombination
and DNA double-strand break repair (Miller et al., 2002).
CHAF1B (fc:1 1.435, DON5) is part of the complex CAF-1 and
the only subunit available on the Chicken Genome Array.
The complex is related to nucleotide excision repair and to
the repair of single-strand breaks (Mello et al., 2002). RIF1
(fc: 11.235, DON5) functions as a DNA damage response
factor (Silverman et al., 2004). XPAC (fc: 11.279, DON5) is
involved in nucleotide excision repair (Shimamoto et al., 1995).
In male broiler chickens fed with 10 mg DON/kg feed, a comet
assay was performed in spleen leukocytes, which detected
aberrations, and a significantly higher amount of DNA breaks
were found (Frankic et al., 2006). Interestingly, all the DNA
repair-related genes mentioned above were only upregulated
in group DON5 with the exception of RAD51L1, which was
upregulated in DON2.5. Genes such as PARP1, MPG, EME1,
XPAC and CHAF1B belong either to the base excision repair or
to the nucleotide excision repair pathway. Under reduced
activity of AKR1B1, the anchorage of lipid aldehydes to the
DNA might have occurred with a higher frequency, and
therefore the discussed single-strand repair genes might have
shown a higher expression in the group DON5. A single-strand
break or modified nucleotides do not lead necessarily to
double-strand breaks or, as a result, to detection in the
comet assay. Continuing, it seems that the activation of DNA
damage-related genes is induced only by a concentration of
4.42 mg DON/kg feed.
Translation initiation
The expression decrease of EIF2AK3 (fc:21.286, DON2.5/5)
could be confirmed in the liver with qPCR (fc: 21.70).
EIF2AK3 is a target for transcriptional upregulation of the
unfolded protein response and phosphorylates eIF2a, a
translation initiator (Yang et al., 2000). The phosphorylation
of eIF2a inhibits translation initiation and protein synthesis.
EIF2AK3 activation and the subsequent eIF2a phosphoryla-
tion prevent the cell from the accumulation of incorrectly
folded or unfolded proteins (Ron, 2002). DNAJC3 (fc: 21.435,
DON2.5) is induced during endoplasmic reticulum (ER)
stress (van Huizen et al., 2003). DNAJC3 binds to EIF2AK3
and disrupts the activity of EIF2AK3. Subsequently, eIF2a
phosphorylation by EIF2AK3 is reduced, stimulating the
eIF2a-induced protein synthesis (Gale et al., 1998). Our results
are consistent with the publication of Yang et al. (2000), which
showed reduced expression level of DNAJC3 after 24 h in
murine thymoma cell line EL-4 treated with DON. The bind-
ing of DON to the 60 S ribosomal subunit and the sub-
sequent translation inhibition might be counterbalanced by
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Figure 1 Heatmap of cluster analysis. Heatmap: green, upregulated genes;
black, normal expression; red, down-regulated genes. The regulation is
displayed according to significant alterations between control group and
DON-containing groups. Each horizontal line corresponds to a normalised
expression of a gene from the respective sample.
Fusarium mycotoxin-contaminated wheat alters the gene expression of broilers
287
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S1751731111001601
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 18:03:39, subject to the Cambridge Core terms of use, available at
the downregulation of EIF2AK3 and DNAJC3. Pestka (2010)
assumed that EIF2AK3 might have an important role in the
signalling after the challenge with DON, because of influenced
up- and downstream signal transducers. The downregulation
of EIF2AK3 in our experiment confirms this assumption. The
ribotoxic stress response seems to have some pathway ele-
ments similar to the ER stress response, but with inverse gene
expression regulation.
Stabilisation of mRNA
The expression change of EXOSC9 (fc: 21.503, DON5) was
confirmed with qPCR (fc: 21.61) in the liver. EXOSC9 is a
subunit of the exosome, a 30–50 exoribonuclease complex.
This complex processes ribosomal and small nuclear RNAs
and degrades mRNAs. In HeLa extracts, the addition of RNA
containing an adenylate/uridylate-rich element (ARE) increased
their 30–50 exonucleolytic decay rate. The inactivation of
EXOSC9 highly decreased the efficiency of the exonucleolytic
decay, showing the central role of EXOSC9 in mRNA decay
(Mukherjee et al., 2002). In human HEp-2 cells, it has been
shown that the knockdown of EXOSC9 led to a twofold
increase in b-globulin containing an ARE (van Dijk et al., 2007).
The 50–30 exoribonuclease XRN1 (fc: 21.796, DON5) was
numerically downregulated in the microarray experiment and
significantly downregulated in qPCR experiment (fc: 21.25) in
the liver. XRN1 is a component of the alternative 50–30 mRNA
decay pathway (Schilders et al., 2006). The knockdown of
XRN1 led to a 3.5-fold increase of the b-globulin-ARE mRNA.
Therefore, EXOSC9 and XRN1 seem to be involved in the
turnover of ARE-containing transcripts (van Dijk et al., 2007). In
his review, Pestka (2008) summarised the genes with a lower
mRNA decay rate upon DON administration, which are COX-2,
tumour necrosis factor (TNF)-a and interleukin (IL)-6 in macro-
phages and IL-2 in EL-4T-cells. It has been reported that all four
mRNAs are stabilised by ARE in the 30 untranslated region
(Chen et al., 2001, Paschoud et al., 2006, Rajasingh et al.,
2006). The downregulation of EXOSC9 and XRN1 might be the
reason for increased mRNA stability of several ARE-containing
genes in DON-challenged cell cultures. Further, the reduced
mRNA depletion, due to XRN1 and EXOSC9 downregulation,
might have also led to higher mRNA levels in general. In the
final gene list (supplementary files), a disequilibrium exists with
367 upregulated genes and 199 downregulated genes. The
possible higher mRNA amount might compensate for the pos-
sibly reduced translation, due to binding to the 60 S ribosomal
subunit by DON. EXOSC9 and XRN1 seem to be interesting
biomarkers for mRNA stabilisation and the decay rate of ARE-
containing mRNA.
Tight junctions
Cells are connected by intercellular complexes such as
tight junctions and adherens junctions. In Caco-2 cells, it has
been shown that the transepithelial electrical resistance
(TEER) decreased to 30% after 24 h of DON incubation at a
concentration of 2mg/ml. It was mentioned that TEER reflects
the functional tight junctions made of transmembrane proteins
Table 6 RT qPCR results
Liver Jejunum
Microarray Don 2.5 Don 5 Don 2.5 Don 5
Gene name Fc Fc P Fc P Fc P Fc P
AKR1B11 23.511 22.08 ** 22.50 * 21.36 NS 22.49 ***
LAPTM4B 13.058 11.23 NS 11.77 * 11.31 * 21.05 NS
EIF2AK3 21.286 21.64 * 21.70 * 21.18 NS 21.34 NS
MIA2 22.544 21.54 * 21.65 * 21.14 NS 21.35 *
EXOSC9 21.503 11.36 NS 21.61 * 11.14 NS 21.24 NS
TJP1 21.520 11.66 NS 21.66 * 11.15 NS 21.24 NS
XRN1 NS (P, 0.08) 11.03 NS 21.25 * 21.02 NS 21.14 *
SLC7A10 11.263 21.42 NS 11.49 * 21.76 NS 12.52 *
SLC2A51 21.259 21.54 ** 21.05 NS 21.72 ** 21.94 **
SLC16A1 NS 21.11 NS 21.10 NS 21.37 * 21.47 *
SLC27A4 11.424 21.43 NS 21.18 NS 21.68 NS 21.87 *
IFT57 11.953 11.78 ** 11.33 NS 11.38 NS 11.41 NS
CASP1 12.198 21.13 NS 11.04 NS 21.43 ** 21.39 **
EP3001 11.321 21.26 NS 21.60 NS 21.52 *** 21.17 NS
MAPKAPK3 11.299 21.32 NS 21.28 NS 21.15 NS 21.15 NS
STK39 11.650 21.03 NS 21.53 NS 21.22 NS 21.01 NS
TP53I3 12.646 21.07 NS 11.06 NS 11.20 NS 21.14 NS
RT5 reverse transcription; DON5 deoxynivalenol; Fc5 fold change; P5 P-value of Student’s t-test.
n5 5 animals per treatment group.
Fc and P were measured between control and the corresponding DON-containing group.
1Raw value above 80th percentile.
*P, 0.05; **P, 0.01; ***P, 0.001.
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(Sergent et al., 2006). Among the proteins mentioned was TJP1
(fc: 21.52, DON5), which was downregulated in our experi-
ment in the liver, which was also measured with qPCR
(fc:21.66). In porcine intestinal epithelial cells (IPEC-1) and -J2
cells, the treatment with 2mg DON/ml led to disintegrated TJP1
structure and the total amount of TJP1 moderately decreased,
which was measured with the Western blot analysis (Diesing
et al., 2011). It was reported that TJP1 interacts with CLDN3
(fc:11.637, DON1/5; Harhaj and Antonetti, 2004). Pinton et al.
(2009) have shown a decreased CLDN3 protein amount in
IPEC-1 after the treatment with DON for 48 h with a parallel
decrease of TEER. Therefore, the upregulation of CLDN3 might
counterbalance the reduction caused by DON over a feedback
mechanism. The decrease of TEER shows the acute effects in
cell cultures. The extent to which the chronic administration of
DON leads to the same effects has not been reported. The
significant expression change of TJP1 and CLDN3 indicates that
similar effects, such as the decreased TEER in cell cultures,
might also occur in the liver of living animals.
Immune-related genes
The expression of MIA2 (fc: 22.544, DON5) was sig-
nificantly decreased, measured with qPCR in the liver
(fc:21.70) and the jejunum (fc:21.35). MIA2 expression is
regulated by IL-6 and transforming growth factor-beta,
which increased the expression level of MIA2 in human
hepatocytes and in HepG2 cells (Bosserhoff et al., 2003). The
downregulation of MIA2 in the liver and the jejunum may
indicate a reduced amount of IL-6 in the liver cells of broilers.
In murine macrophages, it has been shown that IL1RL1
(fc:11.661, DON2.5/5) exerted anti-inflammatory effects by
the negative regulation of the IL-6 production (Takezako et al.,
2006), which affirmed the previous results with the decreased
MIA2 expression. In vitro experiments with the addition of
DON exhibited that the half-life of the ARE-containing IL-6
and TNF-a mRNA and the amount of the respective proteins
were increased within 24 h (Wong et al., 2001). IL-6 seems
to be critical for the regulation of immunoglobulin (Ig)A. In
broilers fed with 7 to 9.2 mg DON/kg feed, the biliary IgA
concentration was decreased (Swamy et al., 2002). Azcona-
Olivera et al. (1995) showed an increased expression of IL-1b,
IL-6 and TNF-a mRNA in mice exposed to a 25 mg DON/kg
diet. Four hours after the administration of DON, the cytokines
were again only slightly upregulated in the liver (Azcona-
Olivera et al., 1995). This may also explain the findings that
IL-1b, IL-6 and TNF-a mRNA were unchanged in our experi-
ment. IL1RL1 might be an antagonist to DON by stabilising IL-6
and TNF-a levels. Especially in long-term administration of
DON, the normalisation of the mRNA and cytokine levels might
be economical. The upregulation of pro- and anti-inflammatory
factors may influence the sensitivity of the immune system and
act as immune stimulators. LAPTM4B (13.058, DON1/5) expres-
sion increase could be confirmed in the liver (fc: 11.77,
DON5) and the jejunum (fc: 11.31, DON2.5). LAPTM4B is a
tetra-transmembrane glycoprotein localised on endosomes
and lysosomes (Liu et al., 2009). LAPTM4B was also upre-
gulated in the early phase of liver regeneration in rats
(Xu et al., 2005). Therefore, LAPTM4B might be used as a
biomarker for liver regeneration.
Conclusion
We could confirm several results in the living animal from
previous studies, which were performed mainly in cell cul-
tures. The main effects with economic impact might be the
altered expression of the solute carrier transcripts, which
transport D-glucose/D-fructose, palmitic acid, monocarboxylates,
L-serine, leucine and other amino acids. Further, the translation
initiation-related genes EIF2AK3 and DNAJC3, as well as the
mRNA stabilisation genes, could have an important influence
on the protein synthesis rate and on the growth of broilers. The
upregulation of DNA repair proteins indicates possible muta-
genic effects of DON or its decomposition products. The
detoxification enzyme AKR1B1 is an indicator that, at 2.21 mg
DON/kg feed, the concentration might be high enough to show
cytotoxic effects. The verification of the results in the jejunum
from the microarray and the qPCR analysis in the liver increases
the reliability of the DON-regulated genes. In general, effects on
the level of RNA expression cannot be directly transposed from
one organ to the other. Therefore, the parallel alterations in the
liver and the jejunum might indicate a general functional
mechanism of DON on the different relative amounts of tran-
scripts. The maximum-allowed DON contamination in poultry
feed in the European Union (2006) is 5 mg DON/kg feed.
Significantly altered gene expression was observed at a con-
centration of 2.21 mg DON/kg feed.
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